Long-term outcomes of helper peptide vaccination for metastatic melanoma.
about
Advances in Immunotherapy for Melanoma: A Comprehensive Review.Vaccines targeting helper T cells for cancer immunotherapy.Current status and future prospects of peptide-based cancer vaccines.Gaining ground on a cure through synergy: combining checkpoint inhibitors with cancer vaccines.Turbocharging vaccines: emerging adjuvants for dendritic cell based therapeutic cancer vaccines.Immunotherapy of cancers comes of age.
P2860
Long-term outcomes of helper peptide vaccination for metastatic melanoma.
description
2015 nî lūn-bûn
@nan
2015 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Long-term outcomes of helper peptide vaccination for metastatic melanoma.
@ast
Long-term outcomes of helper peptide vaccination for metastatic melanoma.
@en
type
label
Long-term outcomes of helper peptide vaccination for metastatic melanoma.
@ast
Long-term outcomes of helper peptide vaccination for metastatic melanoma.
@en
prefLabel
Long-term outcomes of helper peptide vaccination for metastatic melanoma.
@ast
Long-term outcomes of helper peptide vaccination for metastatic melanoma.
@en
P2093
P2860
P1433
P1476
Long-term outcomes of helper peptide vaccination for metastatic melanoma.
@en
P2093
Christopher M Blackwell
P2860
P304
456-64; discussion 462-4
P356
10.1097/SLA.0000000000001419
P407
P577
2015-09-01T00:00:00Z